Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). - Klapper, W.; Stoecklein, H.; Zeynalova, S.; Ott, G.; Kosari, F.; Rosenwald, A.; Loeffler, M.; Trumper, L.; Pfreundschuh, M.; Siebert, R. (Leukemia, 2008)